Biogen stock was headed higher Wednesday, to bounce off an 11-year closing low, after the biotechnology company received positive news from regulators about its treatment for kidney-transplant rejections.
More Stories
European companies could still beat earnings estimates, Barclays says
European companies are heading into the upcoming earnings season on shaky ground, but lowered earnings estimates could help them beat...
Economy ranks as No. 1 issue for Republican voters, but it’s not in Democrats’ top 5, poll finds
Ahead of next month’s election, a new Gallup poll has found no overlap at all between Republican and Democratic voters...
‘I am now an empty nester’: I encouraged my two adult sons to move out. I was anxious and scared — now my heart is full
‘With the sale of the house, I was able to pay off some small debts, and now I am 100%...
Reddit stock climbs after Jefferies initiates coverage with a buy rating
Jefferies estimates that Reddit’s Ebitda will more than double in the next two years to around $450 million.
Inflation still slowing, CPI to show, but some warning signs might flash
The rate of U.S. inflation is likely to slow again in September, but fresh doubts have emerged about whether the...
How this 34-year-old went from working in retail to owning her own restaurant
Jackie Podhurst worked for Target and Macy’s before opening a restaurant in New Jersey.